ADMA BIOLOGICS INC - COMMON STOCK

ADMA Biologics Announces a Poster Presentation at the 2021 International Society for Influenza and other Respiratory Virus Diseases - World Health Organization Conference

19 окт 2021 06:00:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Strengthens its Board of Directors with the Appointment of Young T. Kwon, Ph.D.

18 окт 2021 06:00:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces the Presentation of Real-World Experience in the Management of Respiratory Syncytial Virus (RSV) Presented at IDWeek 2021

04 окт 2021 06:00:01 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces Presentation on Respiratory Viral Infections at IDWeek 2021

01 окт 2021 06:00:00 Источник Nasdaq GlobeNewswire

ADMA Biologics to Virtually Participate in the Cantor Healthcare Conference

23 сен 2021 06:00:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Receives FDA Approval for VanRx Aseptic Fill-Finish Machine and Related Operations

08 сен 2021 06:00:00 Источник Nasdaq GlobeNewswire

ADMA Biologics to Virtually Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

02 сен 2021 06:00:01 Источник Nasdaq GlobeNewswire

ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Maryville, TN

16 авг 2021 06:00:01 Источник Nasdaq GlobeNewswire

ADMA Biologics Reports Record Second Quarter 2021 Financial Results and Highlights Recent Progress and Accomplishments

11 авг 2021 15:05:01 Источник Nasdaq GlobeNewswire

ADMA Biologics Advances Expansion Plans and Opens New Plasma Collection Center in Conyers, GA; ADMA Implements Haemonetics’ Persona Technology for NexSys Plasma Collection System

10 авг 2021 15:30:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces Commercial Availability of Expanded Vial Size Offerings for BIVIGAM® and NABI-HB®

09 авг 2021 06:00:01 Источник Nasdaq GlobeNewswire

ADMA Biologics to Report Second Quarter 2021 Financial Results on August 11, 2021

04 авг 2021 06:00:03 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces Successful Completion of FDA Pre-Approval Manufacturing Facility Inspection

20 июл 2021 06:00:01 Источник Nasdaq GlobeNewswire

ADMA Biologics to Participate in the Raymond James Human Health Innovation Virtual Conference

14 июн 2021 06:00:00 Источник Nasdaq GlobeNewswire

ADMA Biologics to Participate in the Jefferies Virtual Healthcare Conference

26 май 2021 06:00:01 Источник Nasdaq GlobeNewswire

ADMA Biologics Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress and Accomplishments

12 май 2021 15:05:02 Источник Nasdaq GlobeNewswire

ADMA Biologics to Report First Quarter 2021 Financial Results on May 12, 2021

05 май 2021 06:00:01 Источник Nasdaq GlobeNewswire

ADMA Biologics Receives FDA Approval for Increased IVIG Production Scale

28 апр 2021 06:00:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Opens Newest ADMA BioCenters Plasma Collection Facility in Goose Creek, S.C.

26 апр 2021 07:00:02 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces Poster Presentation Highlighting Pharmacoeconomic Burden of HIV and HBV Infection in Sexual Assault Patients at the 2021 Academy of Managed Care Pharmacy Virtual Annual Meeting

13 апр 2021 07:00:01 Источник Nasdaq GlobeNewswire